BIA
IART icon

Bell Investment Advisors’s Integra LifeSciences IART Stock Holding History

Bell Investment Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28
Closed -$993 – 1952
2024
Q1 		$993 Hold
28
– – ﹤0.01% 1605
2023
Q4 		$1.22K Sell
28
-45
-62% -$1.77K ﹤0.01% 1522
2023
Q3 		$2.79K Hold
73
– – ﹤0.01% 1124
2023
Q2 		$3K Sell
73
-9
-11% -$433 ﹤0.01% 1090
2023
Q1 		$4.71K Hold
82
– – ﹤0.01% 822
2022
Q4 		$4.6K Sell
82
-1
-1% -$51 ﹤0.01% 854
2022
Q3 		$4K Buy
83
+2
+2% +$102 ﹤0.01% 792
2022
Q2 		$4K Buy
+81
New +$4.87K ﹤0.01% 801
2021
Q4 		$5K Hold
73
– – ﹤0.01% 765
2021
Q3 		$5K Buy
+73
New +$5.16K ﹤0.01% 714

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bell Investment Advisors's IART Position: Q2 2024 in Review

Bell Investment Advisors sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 28 shares — an estimated $993 sold.

Bell Investment Advisors first reported a position in IART in Q3 2021 and held it in 10 quarters. The position peaked at $5K in Q4 2021. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Bell Investment Advisors reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Bell Investment Advisors sold 28 Integra LifeSciences shares in Q2 2024, an estimated $993.
  • Bell Investment Advisors first reported a position in Integra LifeSciences in Q3 2021 and held it in 10 quarters.
  • Bell Investment Advisors's Integra LifeSciences position peaked at $5K in Q4 2021.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Bell Investment Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.